Exciting News about Element Biosciences!

Element Raises $80M in Series B Financing to Accelerate Development of a New Sequencing Platform

January 9, 2020

SAN DIEGO, Calif. — Element Biosciences today announced the close of a Series B financing round of $80.3 million, with participation from new investors Fidelity Management & Research Company and JS Capital LLC, as well as existing investors Foresite Capital and Venrock. To date, the company has raised a total of more than $100 million. Proceeds from the financing will be used to accelerate the development of high-quality, low-cost, and easy-to-use genomic sequencing solutions.

Element Biosciences Moves to Alexandria GradLabs in Anticipation of Growth and Expansion

December 16, 2019

Element Biosciences took an exciting step toward our future growth. We recently moved our headquarters in San Diego to Alexandria GradLabs in University Town Center! GradLabs is an amazing new idea from a fellow innovator, Alexandria Real Estate Equities, Inc. – it provides early-stage life science companies with turnkey, fully furnished office/lab suites designed to engage talents, maximize efficiencies, and inspire discovery and collaborations.

Element Biosciences Secures $15 Million Series A Financing Led by Foresite Capital and Venrock

July 19, 2019

SAN DIEGO, Calif. — Element Biosciences, Inc., a company focused on the development of genetic analysis tools secures $15 million in Series A funding led by Foresite Capital and Venrock. Proceeds from the financing will support the development of disruptive technologies designed to significantly improve quality and reduce the cost of genomic applications.

© 2020 Element Biosciences, Inc. All rights reserved.